EFTA00630141.pdf
PDF Source (No Download)
Extracted Text (OCR)
From: Deepak Chopra
To: jeffrey E. <jeevacation@gmail.com>
Subject: Re: Fw: Exploring the placebo effect
Date: Mon, 01 Aug 2016 00:39:58 +0000
yes sir I
The Chopra Foundation
lir
Super Genes: Unlock the Astonishing Power of Your DNA for Optimum Health and Wellbeing
From: jeffrey E. <jeevacation@gmailcom>
Sent: Sunday, July 31, 2016 8:39:15 PM
To: Deepak Chopra
Subject: Re: Fw: Exploring the placebo effect
how much fun.
On Sun, Jul 31, 2016 at 8:23 PM, Deepak Chopra
Thanks to you !
The Chopra Foundation
> wrote:
Super Genes: Unlock the Astonishing Power of Your DNA for Optimum Health and Wellbeing
From: Freda Lewis-Hall • c
>
Sent: Sunday, July 31, 2016 8:06 PM
To: Deepak Chopra
Cc: Eric Schadt; Rudolph Tanzi; Carolyn Rangel
Subject: Re: Exploring the placebo effect
This is indeed very interesting! I am currently in Cuba. But will reach out to the team as soon as I return!
EFTA00630141
Hope you are having an enjoyable and productive summer.
Freda
Sent from my iPhone
On Jul 31, 2016, at 7:58 PM, Deepak Chopra
wrote:
Dear Freda
Our study on the effects of meditation on Gene expression will be published soon in Nature Translational
Psychiatry . Eric Schadt was the lead scientist in that study and Rudy as well. See his note that I'm
forwarding . Perhaps he and I and Rudy if he is available can come and pay you a visit at your Pfizer office in
NYC . I think this is worth exploring . Do let us know.
Love
The Chopra Foundation
Super Genes: Unlock the Astonishing Power of Your DNA for Optimum Health and Wellbeing
From: Schadt, Eric
Sent: Sunday, July 31, 2016 7:37 PM
To: Deepak Chopra; Rudolph Tanzi
Subject: Exploring the placebo effect
Deepak and Rudy,
Given the identification of a strong "vacation" and "meditation" molecular response signature in your SOS study, I
became interest in whether such a molecular response could exist in the placebo arms of clinical trials. As you know,
in the placebo arms of clinical trials there is almost always what is known as a placebo effect in which those receiving
the placebo realize a significant response to the placebo that improves the condition of the trial participant in a way
that directly relates to the primary hypothesis of the trial (i.e., those in the placebo arm realize a benefit from the
placebo as anticipated for the drug arm of the trial).
I have been interested in whether those who respond to the placebo have a molecular profile in blood or other tissues
collected in the trial that differs significantly from those who do not respond to the placebo. Today it is the placebo
effect is acknowledged in nearly every single clinical trial. In fact, in your SOS study, controlling for the "vacation"
effect was in my opinion somewhat akin to controlling for the placebo effect with respect to the meditation
intervention. Deriving a molecular signature for the placebo effect would have many advantages that would aid in our
understanding of wellness, establish whether a placebo response may relate to the vacation and/or meditation effects,
and help elucidate the causes of the placebo effect that may aid those running clinical trials in better accounting for
such effects and distinguishing them from the action of a drug (it would almost certainly significantly improve the
power in clinical trials to demonstrate the efficacy of a drug).
I think there may be significant data already available toward this end. I think assembling these data, perhaps going
to pharma as well and seeing how many blood samples exist from the placebo arm of clinical trials that could be
EFTA00630142
molecularly profiled as we did in your study (i.e., there may be many samples in clinical studies already run and we
simply identify the extreme responders and non-responders in the placebo arms and profile those), would be worth
some effort. I think pharma would be open to this given the placebo arm of the trials are unrelated to the drug arm
that they typically want to keep very protected.
Worth a discussion! Let me know if any interest.
Eric
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00630143
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Dates
Email Addresses
Document Details
| Filename | EFTA00630141.pdf |
| File Size | 150.0 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 4,706 characters |
| Indexed | 2026-02-11T23:10:40.758277 |